Regulation of cytochrome P450 by inflammatory mediators: Why and how?

Drug Metabolism and Disposition

Volumn 29, Issue 3, 2001, Pages 207-212

  Morgan, E T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450;

CATALYSIS; CELL TYPE; DRUG CLEARANCE; DRUG METABOLISM; MEDIATOR RELEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SHORT SURVEY; TOXIN ANALYSIS; TRANSCRIPTION REGULATION;

ANIMALS; ARACHIDONIC ACID; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; DOWN-REGULATION; HOMEOSTASIS; HUMANS; INFLAMMATION; LIVER; NITRIC OXIDE; OXIDATIVE STRESS; PHARMACEUTICAL PREPARATIONS; REACTIVE OXYGEN SPECIES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS;

EID: 0035119064     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (57)

1. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture
2. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response
3. Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-α dependent
4. Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: Treatment with NG-monomethyl-L-arginine
5. New role for epoxyeicosatrienoic acids as anti-inflammatory mediators
6. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450
7. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals
8. Stable expression of human cytochrome P4502El in HepG2 cells: Characterization of catalytic activities and production of reactive oxygen intermediates
9. 4 pathway to inflammation control
10. Role of reactive oxygen intermediates in the decrease of hepatic cytochrome P450 activity by serum of humans and rabbits with an acute inflammatory reaction
11. Inhibitors of cytochrome P450 suppress tumor necrosis factor production
12. The upregulating effect of dexamethasone on tumor necrosis factor production is mediated by a nitric oxide-producing cytochrome P450
13. Nifedipine increases cytochrome P4502C expression and endotbelium-derived hyperpolarizing factor-mediated responses in coronary arteries
14. Glutathione regulates nitric oxide synthase in cultured hepatocytes
15. Suppression of CYP2C11 gene transcription by interleukin-1 mediated by NFκB binding at the transcription start site
16. Induction and regulation of cytochrome P450 K-5 (lauric acid hydroxylase) in rat renal microsomes by starvation
17. Re-expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells
18. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction
19. Proinflammatory mediators chronically down-regulate the formation of the endothelium-derived hyperpolarizing factor in arteries via a nitric oxide/cyclic GMP-dependent mechanism
20. Evidence for ritric oxide participation in down-regulation of CYP2B1/2 gene expression at the pretranslational level
21. Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis
22. Role of cytochrome P-450 in endogenous antipyresis
23. Cytochrome P450111A activity and cytokine-mediated synthesis of nitric oxide
24. Expression of CD14 by hepatocytes: Upregulation by cytokines during endotoxemia
25. Kupffer cell-mediated differential down-regulation of cytochrome P450 metabolism in rat bepatocytes
26. Characterization of CYP4A induction in rat liver by inflammatory stimuli: Dependence on sex, strain and inflammation-evoked hypophagia
27. Down-regulation of cytochrome P450 1A1 gene promoter by oxidative stress. Critical contribution of nuclear factor 1
28. Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotokin
29. Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo. Independence from the hypothalamo-pituitary axis
30. Regulation of cytochromes P450 during inflammation and infection
31. Nitric oxide mediates hepatic cytochrome P450 dysfunction induced by endotoxin
32. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture
33. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids
34. Endotoxin stimulates hepatocyte interleukin-6 production
35. Induction of cytochrome P4501A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin or indolo(3,2-b)carbazole is associated with oxidative DNA damage
36. Hepatitis A impairs the function of human hepatic CYP2A6 in vivo
37. ω-hydroxyarginine to citrulline and nitrogen oxides and occurrence in NO synthasas of a sequence very similar to the heine-binding sequence in P450s
38. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaneharide-evoked localized inflammation in brain
39. Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1
40. Expression and distribution of cytochrome P450 enzymes in male rat kidney: Effects of ethanol, acetone and dietary conditions
41. Down-regulation of cytochrome P450 mRNAs and proteins in mice lacking a functional NOS2 gene
42. Differential inductive and suppressive effects of endotoxin and paniculate irritants on hepatic and renal cytochrome P-450 expression
43. Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1β and endotoxin in primart rat hepatocytes
44. Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production
45. Gender differences in drug metabolism regulated by growth hormone
46. Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women
47. Differential alterations in levels of hepatic microsomal cytochrome P450 isozymes following intracerebroventricular injection of bacterial lipopolysaccharide in rats
48. Mechanism of decrease in levels of hepatic P450 isozymes induced by intracerebral endotoxin: Independence from sympathetic nervous and adrenocortical systems
49. cAMP-associated inhibition of phenobarbital-inducible cytochrome P450 gone expression in primary rat hepatocyte cultures
50. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent
51. Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia
52. Ah receptor and NF-κB interactions, a potential mechanism for dioxin toxicity
53. Induction of cytochrome P450 2E1 expression in rat and gerbil astrocytes by inflammatory factors and ischemic injury
54. Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes
55. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors
56. Hepatic cytochrome P-450 expression in tumor necrosis factor-α receptor (p55/p75) knockout mice after endotoxin administration
57. Oxygen activation by cytochrome P-450